 random trial singl bolu dosag regimen recombin tissu plasminogen activ patient acut pulmonari embol experi anim recombin tissu plasminogen activ rt-pa thrombolysi circul thrombolysi bleed rt-pa short period previou studi patient thrombot diseas rt-pa effect thrombolyt agent continu infus period minut hour short cours regimen rt-pa thrombolysi double-blind random trial patient acut symptomat pulmonari embol heparin infus rt-pa dose mg/kg patient salin placebo patient perfus scan chang pulmonari perfus hour day post-studi drug administr percent rt-pa patient percent resolut perfus defect hour percent placebo patient hour mean rel improv perfus defect percent rt-pa treat patient percent placebo group day differ lung scan resolut group major bleed group differ transfus requir group minor bleed rt-pa patient angiogram-cathet insert venipunctur site result bolu regimen rt-pa produc thrombolysi altern conveni approach thrombolyt therapi patient pulmonari embol